Loading clinical trials...
Loading clinical trials...
Objective to evaluate the effect of Shexiang Baoxin Pill on myocardial ischemia in patients with coronary microvascular dysfunction (non obstructive coronary heart disease) through a randomized, doubl...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shanghai Hutchison Pharmaceuticals Limited
NCT07493603 · Coronary Heart Disease, Coronary Artery Disease, and more
NCT07451873 · Coronary Heart Disease
NCT06788275 · Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, and more
NCT06216847 · Coronary Heart Disease (CHD)
NCT07149688 · Atrial Fibrillation (AF), Hypertension, and more
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions